Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength

Author:

Haber Noah AORCID,Clarke-Deelder Emma,Feller Avi,Smith Emily R,Salomon Joshua A.,MacCormack-Gelles Benjamin,Stone Elizabeth M,Bolster-Foucault Clara,Daw Jamie R,Hatfield Laura AnneORCID,Fry Carrie E,Boyer Christopher B,Ben-Michael Eli,Joyce Caroline M,Linas Beth S,Schmid Ian,Au Eric H,Wieten Sarah E,Jarrett BrookeORCID,Axfors Cathrine,Nguyen Van Thu,Griffin Beth Ann,Bilinski Alyssa,Stuart Elizabeth A

Abstract

IntroductionAssessing the impact of COVID-19 policy is critical for informing future policies. However, there are concerns about the overall strength of COVID-19 impact evaluation studies given the circumstances for evaluation and concerns about the publication environment.MethodsWe included studies that were primarily designed to estimate the quantitative impact of one or more implemented COVID-19 policies on direct SARS-CoV-2 and COVID-19 outcomes. After searching PubMed for peer-reviewed articles published on 26 November 2020 or earlier and screening, all studies were reviewed by three reviewers first independently and then to consensus. The review tool was based on previously developed and released review guidance for COVID-19 policy impact evaluation.ResultsAfter 102 articles were identified as potentially meeting inclusion criteria, we identified 36 published articles that evaluated the quantitative impact of COVID-19 policies on direct COVID-19 outcomes. Nine studies were set aside because the study design was considered inappropriate for COVID-19 policy impact evaluation (n=8 pre/post; n=1 cross-sectional), and 27 articles were given a full consensus assessment. 20/27 met criteria for graphical display of data, 5/27 for functional form, 19/27 for timing between policy implementation and impact, and only 3/27 for concurrent changes to the outcomes. Only 4/27 were rated as overall appropriate. Including the 9 studies set aside, reviewers found that only four of the 36 identified published and peer-reviewed health policy impact evaluation studies passed a set of key design checks for identifying the causal impact of policies on COVID-19 outcomes.DiscussionThe reviewed literature directly evaluating the impact of COVID-19 policies largely failed to meet key design criteria for inference of sufficient rigour to be actionable by policy-makers. More reliable evidence review is needed to both identify and produce policy-actionable evidence, alongside the recognition that actionable evidence is often unlikely to be feasible.

Publisher

BMJ

Subject

General Medicine

Reference73 articles.

1. Making Decisions in a COVID-19 World

2. COVID-19 Statistics, Policy modeling, and Epidemiology Collective . Defining high-value information for COVID-19 decision-making. Health Policy 2020.

3. Hernán MA , Robins JM . Causal inference: what if. Boca Raton: Chapman & Hall/CRC.

4. Angrist J , Pischke J-S . Mostly harmless econometrics: an empiricist’s companion. 1st edn. Princeton University Press, 2009. https://EconPapers.repec.org/RePEc:pup:pbooks:8769

5. Goodman-Bacon A , Marcus J . Using difference-in-differences to identify causal effects of COVID-19 policies. SSRN Journal 2020.doi:10.2139/ssrn.3603970

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3